13F
中

MNPR MONOPAR THERAPEUTICS INC

2026Q1 · CUSIP 61023L207 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
80
Δ holders QoQ
+6
Breadth percentile
Top 39%
Whale holders
47
Δ whales
+2
Inst. holding value
$341M
New positions
20
Closed positions
14
Price momentum (1Q)
+3.8%
Put / Call
0/0

Breadth history (34 quarters)

2024Q4: Δ+12 · h=19 2025Q1: Δ+17 · h=36 2025Q2: Δ+8 · h=44 2025Q3: Δ+12 · h=56 2025Q4: Δ+18 · h=74 2026Q1: Δ+6 · h=80 2024Q4: holders=19 2025Q1: holders=36 2025Q2: holders=44 2025Q3: holders=56 2025Q4: holders=74 2026Q1: holders=80 -18 -9 +0 +9 +18 175184 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 14% -9.2% +107.1%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.93
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2025-03-31: EPS -0.38 2025-06-30: EPS -0.35 2025-09-30: EPS -0.48 2025-12-31: EPS -0.64 2026-03-31: EPS -0.46 -0.70 -0.35 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)